georgetown semaglutide Free Consultation NEW Apo-Semaglutide Pens Now Available

To maintain potency, store unused Ozempic pens in the refrigerator at 2C8C (36F46F)

BPS Publications bpspubs.onlinelibrary.wiley.com To view or add a comment, sign in Methylene Blue in Clinical Practice: From FDA-Approved Methemoglobinemia Reversal to Off-Label Applications, Serotonergic Risks, and Safety --- -- -- Dr Indunil Karunarathna Uva Clinical Research Lab 2026 Uva Clinical Anaesthesia and Intensive Care ISSN 2827-7198, 2026 Methylene blue (methylthioninium chloride) DOI:10.5281/zenodo.20674932 is a century-old synthetic thiazine dye with a distinctive pharmacodynamic profile that encompasses redox cycling, alternative electron transport, and enzymatic inhibition

While these antioxidants hold great promise for OA treatment, further studies are required to validate their safety and efficacy before clinical application

however, as with all prescribed and over the counter preparations, we still need to remain vigilant. The research comes just weeks after the Therapeutic Goods Administration (TGA) issued firm advice not to initiate semaglutide prescriptions without a compelling clinical reason

According to the MHRA/EMC SmPC for Wegovy, the most frequently reported gastrointestinal side effects include: Nausea the most common adverse effect, affecting approximately 44% of patients in clinical trials, typically most pronounced during dose escalation Diarrhoea reported in around 30% of patients, ranging from mild to moderate severity Constipation affecting approximately 24% of patients, related to slowed gut transit Vomiting occurring in roughly 24% of patients, often associated with nausea Abdominal pain or discomfort reported by approximately 20% of patients Dyspepsia (indigestion) affecting around 9% of patients Bloating and flatulence commonly reported but less precisely quantified in trials These side effects are dose-dependent , meaning they tend to be more pronounced at higher doses and during the escalation phase